| Literature DB >> 34901175 |
Ralph M Trüeb1, Michela V R Starace2, Bianca Maria Piraccini2, Hudson Dutra Rezende3, Maria Fernanda Reis Gavazzoni Dias4.
Abstract
Trichodynia refers to the painful sensation of the scalp related to the complaint of hair loss. Originally suggested to be distinguishing for telogen effluvium and related to hair loss activity and follicular inflammation, further studies have found trichodynia to be common in androgenetic alopecia as well and coexisting with psychopathologic findings. The respective studies failed to demonstrate correlations between trichodynia and quantifiable hair loss activity, nor histopathologic evidence for follicular inflammation. A symptomatic scalp is a frequent condition in specific dermatological conditions of the scalp. By definition of exclusion, we are not dealing with trichodynia in these cases. It is conceivable that neuropeptides are key players between the central nervous system and the skin immune and microvascular system. Such mechanisms would explain the noxious effects of both external stimuli and emotional distress in eliciting cutaneous nociception. Since we have begun to understand the diverse etiologies of trichodynia, and a single term does not measure up to this circumstance, it may be wiser to describe the condition depending on the type of scalp sensation and its specific disease association. Further studies are warranted into the neural/endothelial/follicular interactions both in hair growth and shedding and the psychosomatic diseases of the hair and scalp.Entities:
Keywords: Botulinum toxin; Neuropeptide substance P; Scalp dysesthesia; Symptomatic scalp; Trichodynia
Year: 2021 PMID: 34901175 PMCID: PMC8613582 DOI: 10.1159/000517463
Source DB: PubMed Journal: Skin Appendage Disord ISSN: 2296-9160